These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3240 related articles for article (PubMed ID: 24821456)

  • 1. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.
    Chéreau N; Buffet C; Trésallet C; Tissier F; Leenhardt L; Menegaux F
    Surgery; 2016 Mar; 159(3):755-62. PubMed ID: 26435440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
    Zhao H; Huang T; Li H
    Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The number of positive lymph nodes in the central compartment has prognostic impact in papillary thyroid cancer.
    Rajeev P; Ahmed S; Ezzat TM; Sadler GP; Mihai R
    Langenbecks Arch Surg; 2013 Mar; 398(3):377-82. PubMed ID: 23274361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
    Hall CM; Snyder SK; Maldonado YM; Lairmore TC
    Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience and analysis of Delphian lymph node metastasis in patients with papillary thyroid carcinoma.
    Kim WW; Yang SI; Kim JH; Choi YS; Park YH; Kwon SK
    World J Surg Oncol; 2012 Oct; 10():226. PubMed ID: 23110552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma.
    Kim HJ; Park HK; Byun DW; Suh K; Yoo MH; Min YK; Kim SW; Chung JH
    Head Neck; 2015 May; 37(5):650-4. PubMed ID: 24590814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of prophylactic modified radical neck dissection for patients with low-risk papillary thyroid carcinoma measuring 1.1-3.0 cm: first report of a trial at Kuma Hospital.
    Ito Y; Tsushima Y; Masuoka H; Yabuta T; Fukushima M; Inoue H; Tomoda C; Kihara M; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
    Surg Today; 2011 Nov; 41(11):1486-91. PubMed ID: 21969150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical extent of central lymph node dissection in clinically node-negative papillary thyroid cancer.
    Kim WW; Park HY; Jung JH
    Head Neck; 2013 Nov; 35(11):1616-20. PubMed ID: 23322499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery.
    Conzo G; Mauriello C; Docimo G; Gambardella C; Thomas G; Cavallo F; Tartaglia E; Napolitano S; Varriale R; Rossetti G; Fei L; Santini L
    Int J Surg; 2014; 12 Suppl 1():S194-7. PubMed ID: 24862675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Extranodal Extension in Thyroid Cancer: A Meta-Analysis.
    Suh S; Pak K; Seok JW; Kim IJ
    Yonsei Med J; 2016 Nov; 57(6):1324-8. PubMed ID: 27593858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and indication for dissection of right paraesophageal lymph node metastasis in papillary thyroid carcinoma.
    Zhang L; Liu H; Xie Y; Xia Y; Zhang B; Shan G; Li X
    Eur J Surg Oncol; 2016 Jan; 42(1):81-6. PubMed ID: 26615455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and significance of Delphian node metastasis in papillary thyroid cancer.
    Iyer NG; Kumar A; Nixon IJ; Patel SG; Ganly I; Tuttle RM; Shah JP; Shaha AR
    Ann Surg; 2011 May; 253(5):988-91. PubMed ID: 21372688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age.
    Wada N; Masudo K; Nakayama H; Suganuma N; Matsuzu K; Hirakawa S; Rino Y; Masuda M; Imada T
    Eur J Surg Oncol; 2008 Feb; 34(2):202-7. PubMed ID: 18023321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma.
    Roh JL; Park JW; Jeong J; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2017 Sep; 116(4):450-458. PubMed ID: 28608492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of patients with papillary thyroid carcinoma showing postoperative recurrence to the central neck.
    Ito Y; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
    World J Surg; 2011 Apr; 35(4):767-72. PubMed ID: 21181469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extranodal extension of metastatic papillary thyroid carcinoma: correlation with biochemical endpoints, nodal persistence, and systemic disease progression.
    Lango M; Flieder D; Arrangoiz R; Veloski C; Yu JQ; Li T; Burtness B; Mehra R; Galloway T; Ridge JA
    Thyroid; 2013 Sep; 23(9):1099-105. PubMed ID: 23421588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 162.